• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Spruce Biosciences Inc (NQ: SPRB )

    0.4700 +0.0051 (+1.10%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Sep 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 194,998
    Open 0.4623
    Bid (Size) 0.4650 (5)
    Ask (Size) 0.4699 (4)
    Prev. Close 0.4649
    Today's Range 0.4502 - 0.4768
    52wk Range 0.4112 - 5.950
    Shares Outstanding 40,710,692
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
    From Spruce Biosciences, Inc.
    Via Business Wire
    SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024
    SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -84.12%
    -84.12%
    1 Month
    +12.52%
    +12.52%
    3 Month
    -29.34%
    -29.34%
    6 Month
    -90.94%
    -90.94%
    1 Year
    -81.50%
    -81.50%

    More News

    Read More
    Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
    From Spruce Biosciences, Inc.
    Via Business Wire
    Major Potential: 5 NASDAQ / NYSE Stocks Under $1 SGMO, FTCI, VTAK, SPRB, DNA
    Via AB Newswire
    Spruce Biosciences Recognized as a Bay Area Best Place to Work
    From Spruce Biosciences, Inc.
    Via Business Wire
    Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder
    Via Benzinga
    Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
    From Spruce Biosciences, Inc.
    Via Business Wire
    SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences to Participate in May Investor Conferences
    From Spruce Biosciences, Inc.
    Via Business Wire
    Pfizer Q1 Earnings and Revenues Beat Estimates
    Via Talk Markets
    Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
    From Spruce Biosciences, Inc.
    Via Business Wire
    Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
    Via Benzinga
    Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    US Stocks Higher; Producer Prices Rise 0.6% In February
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Is Altria Giving Up on Anheuser-Busch (BUD) Stock?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.